Literature DB >> 32234886

Nucleolin and Nucleophosmin Expression in Gleason 3 and Gleason 4 Prostate Cancer With Seminal Vesicles Invasion (pT3b).

Marek Masiuk1, Magdalena Lewandowska2, Ewa Dobak2, Elzbieta Urasinska2.   

Abstract

BACKGROUND/AIM: The aim of this study was to analyze the expression of nucleolin (NCL) and nucleophosmin (NPM) in prostate adenocarcinoma and in its loco-regional spread in the form of seminal vesicle invasion (SVI).
MATERIALS AND METHODS: The study was performed on tissue microarrays of 40 cases of Gleason 3+4 pT3b prostate cancers including tissue samples from SVI. The expression of NCL and NPM was detected immunohistochemically and analyzed with image analysis software.
RESULTS: The expression of NCL and NPM were higher in cancer cells within a prostate gland than in SVI. Gleason 4 pattern showed higher expression of NPM than Gleason 3 pattern cells.
CONCLUSION: Differences in nuclear NCL and NPM expression in cancer cells between the prostate gland and SVI may indicate involvement of these proteins in loco-regional spread of adenocarcinoma of the prostate. Differences in NPM expression in Gleason 3 and Gleason 4 pattern suggest involvement of this protein in the differentiation of prostate cancer. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Gleason grade; Nucleolar proteins; local spread; neoplasm invasiveness; prostate cancer

Mesh:

Substances:

Year:  2020        PMID: 32234886     DOI: 10.21873/anticanres.14152

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Overexpression of Nucleolin and Associated Genes in Prostate Cancer.

Authors:  Virginie Firlej; Pascale Soyeux; Maya Nourieh; Eric Huet; Fannie Semprez; Yves Allory; Arturo Londono-Vallejo; Alexandre de la Taille; Francis Vacherot; Damien Destouches
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K/AKT pathway.

Authors:  Jun Ying; Ruowang Pan; Zhouhao Tang; Jiayin Zhu; Ping Ren; Yang Lou; Enyong Zhang; Dadao Huang; Penghong Hu; Dong Li; Qiyu Bao; Peizhen Li
Journal:  Cancer Med       Date:  2022-02-06       Impact factor: 4.452

3.  Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.

Authors:  Marek Masiuk; Piotr Waloszczyk; Magdalena Lewandowska; Ewa Dobak; Elzbieta Urasinska
Journal:  Thorac Cancer       Date:  2020-07-16       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.